A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTIC SYNDROME IN SEVERE COVID-19 INFECTION: DIAGNOSTIC CHALLENGES AND A CASE DISCUSSION
2022
SCIREA journal of clinical medicine
The hemophagocytic lymphohistiocytic syndrome (HLH) has been reported in critically ill patients with confirmed sars-cov-2 infection and contributes to their morbidity and mortality. Precise criteria for diagnosis and monitoring of HLH in these patients are essential for improving their clinical outcomes. The diagnosis of HLH depends on several clinical, laboratory, and morphologic parameters according to the HLH-2004 guidelines and its update for adult patients. Recently, the H-score tool
doi:10.54647/cm32748
fatcat:udvbch3cmvgmrfgl46n6usf7be